HFA Premium Access

Low dose of basiliximab for induction immunosuppresion therapy for heart transplant results in favourable outcomes

Congress Presentation

About the speaker

Doctor Veraprapas kittipibul

Duke University Health System, Durham (United States of America)
0 follower

7 more presentations in this session

Influence of a continuous veno-venous hemofiltration on the long-term prognosis in patients with an advanced heart failure and an acute coronary syndrome

Speaker: Doctor O. Trebacz (Krakow, PL)

Thumbnail

Beta-blockers uptitration between infusions predicts event-free survival in advanced heart failure treated with repeated cures of low-dose levosimendan

Speaker: Doctor P. Yerly (Lausanne, CH)

Thumbnail

Utility of cTnT-hs and sAXL for prognosis evaluation after heart transplantation

Speaker: Doctor S. Mirabet Perez (Barcelona, ES)

Thumbnail

Predictors of mortality at six months after in advanced heart failure patients attended in primary care

Speaker: Doctor J. Verdu (Barcelona, ES)

Thumbnail

Intermitent treatment with levosimendan in outpatients with chronic advanced heart failure: our experience.

Speaker: Doctor J. Garcia Pinilla (Malaga, ES)

Thumbnail

Access the full session

Poster Session 1 - Advanced heart failure

Speakers: Doctor V. kittipibul, Doctor O. Trebacz, Doctor P. Yerly, Doctor S. Mirabet Perez, Doctor J. Verdu...
Thumbnail

About the event

Image

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations